Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

TP53-mutated MDS and AML

Tundra lists 1 TP53-mutated MDS and AML clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT07094464

Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation

This study aims to explore the safety and efficacy of selinexor combined with azacitidine for maintenance therapy in TP53 mutant AML/MDS patients following transplantation.

Gender: All

Ages: 14 Years - 75 Years

Updated: 2025-07-30

1 state

TP53-mutated MDS and AML

Allogeneic Hematopoietic Stem Cell Transplantation